This hypothesis is consistent with previous reports showing that the Glu496Ala polymorphism, leading to a non-functional P2X7 receptor, is associated with decreased BMD values, i.e. increased osteoporosis risk [37-39]. The gene discussed is P2RX7; the disease is osteoporosis.